Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 245

1.

FDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies.

Benveniste MF, Moran CA, Mawlawi O, Fox PS, Swisher SG, Munden RF, Marom EM.

J Thorac Oncol. 2013 Apr;8(4):502-10. doi: 10.1097/JTO.0b013e3182835549.

2.

Role of combined 18F-FDG-PET/CT for predicting the WHO malignancy grade of thymic epithelial tumors: a multicenter analysis.

Lococo F, Cesario A, Okami J, Cardillo G, Cavuto S, Tokunaga T, Apolone G, Margaritora S, Granone P.

Lung Cancer. 2013 Nov;82(2):245-51. doi: 10.1016/j.lungcan.2013.08.003. Epub 2013 Aug 13.

PMID:
23992878
3.

The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours.

Fukumoto K, Taniguchi T, Ishikawa Y, Kawaguchi K, Fukui T, Kato K, Matsuo K, Yokoi K.

Eur J Cardiothorac Surg. 2012 Dec;42(6):e152-6. doi: 10.1093/ejcts/ezs527. Epub 2012 Sep 28.

PMID:
23024234
4.

Value of 18F-FDG PET/CT for Predicting the World Health Organization Malignant Grade of Thymic Epithelial Tumors: Focused in Volume-Dependent Parameters.

Park SY, Cho A, Bae MK, Lee CY, Kim DJ, Chung KY.

Clin Nucl Med. 2016 Jan;41(1):15-20. doi: 10.1097/RLU.0000000000001032.

PMID:
26545017
5.

¹⁸F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival.

Seki N, Sakamoto S, Karube Y, Oyaizu T, Ishihama H, Chida M.

Ann Nucl Med. 2014 Apr;28(3):257-62. doi: 10.1007/s12149-014-0804-2. Epub 2014 Jan 16.

PMID:
24430867
6.

Utility of 18F-fluorodeoxyglucose positron emission tomography for distinguishing between the histological types of early stage thymic epithelial tumours.

Eguchi T, Yoshida K, Hamanaka K, Shiina T, Koizumi T, Kawakami S, Oguchi K, Amano J.

Eur J Cardiothorac Surg. 2012 May;41(5):1059-62. doi: 10.1093/ejcts/ezr144. Epub 2011 Dec 21.

PMID:
22219437
7.

Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms.

Terzi A, Bertolaccini L, Rizzardi G, Luzzi L, Bianchi A, Campione A, Comino A, Biggi A.

Lung Cancer. 2011 Nov;74(2):239-43. doi: 10.1016/j.lungcan.2011.02.018. Epub 2011 Mar 25.

PMID:
21439670
8.

Usefulness of [18F]fluoro-2-deoxy-D-glucose positron emission tomography for predicting the World Health Organization malignancy grade of thymic epithelial tumors.

Igai H, Matsuura N, Tarumi S, Chang SS, Misaki N, Go T, Ishikawa S, Yokomise H.

Eur J Cardiothorac Surg. 2011 Jul;40(1):143-5. doi: 10.1016/j.ejcts.2010.09.009. Epub 2010 Oct 15.

PMID:
20951602
9.

Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: a preliminary report.

Liu RS, Yeh SH, Huang MH, Wang LS, Chu LS, Chang CP, Chu YK, Wu LC.

Eur J Nucl Med. 1995 Dec;22(12):1402-7.

PMID:
8586085
10.

18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups.

Sung YM, Lee KS, Kim BT, Choi JY, Shim YM, Yi CA.

J Nucl Med. 2006 Oct;47(10):1628-34.

11.

18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.

Toba H, Kondo K, Sadohara Y, Otsuka H, Morimoto M, Kajiura K, Nakagawa Y, Yoshida M, Kawakami Y, Takizawa H, Kenzaki K, Sakiyama S, Bando Y, Tangoku A.

Eur J Cardiothorac Surg. 2013 Aug;44(2):e105-12. doi: 10.1093/ejcts/ezt263. Epub 2013 May 14.

PMID:
23674658
12.

Thymic epithelial tumors: prognostic determinants among clinical, histopathologic, and computed tomography findings.

Moon JW, Lee KS, Shin MH, Kim S, Woo SY, Lee G, Han J, Shim YM, Choi YS.

Ann Thorac Surg. 2015 Feb;99(2):462-70. doi: 10.1016/j.athoracsur.2014.09.050. Epub 2014 Dec 20.

PMID:
25534526
13.

Thymic epithelial tumors: Can fluorodeoxyglucose positron emission tomography help in predicting histologic type and stage?

Purandare NC, Pramesh CS, Karimundackal G, Jiwnani S, Agrawal A, Shah S, Agarwal JP, Prabhash K, Noronha V, Joshi A, Kumar R, Rangarajan V.

Indian J Cancer. 2016 Apr-Jun;53(2):270-273. doi: 10.4103/0019-509X.197717.

14.

¹⁸FDG PET for grading malignancy in thymic epithelial tumors: significant differences in ¹⁸FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study.

Nakajo M, Kajiya Y, Tani A, Yoneda S, Shirahama H, Higashi M, Nakajo M.

Eur J Radiol. 2012 Jan;81(1):146-51. doi: 10.1016/j.ejrad.2010.08.010. Epub 2010 Aug 31.

PMID:
20810231
15.

Diagnostic Utility of PET CT in Thymic Tumours with Emphasis on 68Ga-DOTATATE PET CT in Thymic Neuroendocrine Tumour - Experience at a Tertiary Level Hospital in India.

Hephzibah J, Shanthly N, Oommen R.

J Clin Diagn Res. 2014 Sep;8(9):QC01-3. doi: 10.7860/JCDR/2014/10499.4840. Epub 2014 Sep 20.

16.

Role of fluorine-flurodeoxyglucose positron emission tomography/computed tomography in preoperative assessment of anterior mediastinal masses.

Luzzi L, Campione A, Gorla A, Vassallo G, Bianchi A, Biggi A, Terzi A.

Eur J Cardiothorac Surg. 2009 Sep;36(3):475-9. doi: 10.1016/j.ejcts.2009.03.055. Epub 2009 Jun 5.

PMID:
19501523
17.

18-Fluorine fluorodeoxyglucose positron emission tomography in the pretreatment evaluation of thymic epithelial neoplasms: a metabolic biopsy confirmed by Ki-67 expression.

Viti A, Bertolaccini L, Cavallo A, Fortunato M, Bianchi A, Terzi A.

Eur J Cardiothorac Surg. 2014 Sep;46(3):369-74; discussion 374. doi: 10.1093/ejcts/ezu030. Epub 2014 Feb 28.

PMID:
24585679
18.

Usefulness of fluorine-18 fluorodeoxyglucose-positron emission tomography in management strategy for thymic epithelial tumors.

Matsumoto I, Oda M, Takizawa M, Waseda R, Nakajima K, Kawano M, Mochizuki T, Ikeda H, Watanabe G.

Ann Thorac Surg. 2013 Jan;95(1):305-10. doi: 10.1016/j.athoracsur.2012.09.052. Epub 2012 Nov 28.

PMID:
23200236
19.

Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors.

Endo M, Nakagawa K, Ohde Y, Okumura T, Kondo H, Igawa S, Nakamura Y, Tsuya A, Murakami H, Takahashi T, Yamamoto N, Ito I, Kameya T.

Lung Cancer. 2008 Sep;61(3):350-5. doi: 10.1016/j.lungcan.2008.01.003. Epub 2008 Mar 4.

PMID:
18304691
20.

Combined imaging with 18F-FDG-PET/CT and 111In-labeled octreotide SPECT for evaluation of thymic epithelial tumors.

De Luca S, Fonti R, Palmieri G, Federico P, Del Prete G, Pacelli R, Pace L, De Placido S, Salvatore M, Del Vecchio S.

Clin Nucl Med. 2013 May;38(5):354-8. doi: 10.1097/RLU.0b013e318286bd84.

PMID:
23486323

Supplemental Content

Support Center